Search hospitals > Texas > Houston

Michael E DeBakey VA Medical Center

Claim this profile
Houston, Texas 77030
Global Leader in Post-Traumatic Stress Disorder
Global Leader in Depression
Conducts research for Lung Cancer
Conducts research for Anxiety Disorders
Conducts research for Drug Addiction
401 reported clinical trials
41 medical researchers
Photo of Michael E DeBakey VA Medical Center in HoustonPhoto of Michael E DeBakey VA Medical Center in HoustonPhoto of Michael E DeBakey VA Medical Center in Houston

Summary

Michael E DeBakey VA Medical Center is a medical facility located in Houston, Texas. This center is recognized for care of Post-Traumatic Stress Disorder, Depression, Lung Cancer, Anxiety Disorders, Drug Addiction and other specialties. Michael E DeBakey VA Medical Center is involved with conducting 401 clinical trials across 483 conditions. There are 41 research doctors associated with this hospital, such as Aihua E. Yen, Quillan Huang, Yvonne H. Sada, and Martha Mims, MD, PhD.

Top PIs

Clinical Trials running at Michael E DeBakey VA Medical Center

Bladder Cancer
Prostate Cancer
Post-Traumatic Stress Disorder
Spinal Cord Injury
Epilepsy
Small Cell Lung Cancer
Chronic Pain
Lung Cancer
Depression
Anxiety Disorders
Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Blue Light Cystoscopy

for Bladder Cancer

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Recruiting2 awards N/A2 criteria
Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting2 awards Phase 314 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Michael E DeBakey VA Medical Center?
Where is Michael E DeBakey VA Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Michael E DeBakey VA Medical Center accept?
What awards or recognition has Michael E DeBakey VA Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security